“Initiated coverage on Colgate Palmolive India with a 'Buy' recommendation and a target price of ₹2,166, suggesting a 7.7% upside from August 4 closing. The company benefits from extensive rural reach and market share gains from premium product launches. A debt-free balance sheet, strong return ratios, and consistent cash flow generation are key drivers for this positive stance.”